Function-first antibody discovery
نویسنده
چکیده
Therapeutic antibodies may mediate antineoplastic effects by altering the biological functions of their target, by directly stimulating the demise of cancer cells or by activating antibody-dependent immune effector mechanisms. We have recently provided in vivo proof-of-concept for a "function-first" target and drug discovery platform in which antibodies against a multitude of tumor-associated antigens are screened for biological effects in a target-unbiased manner.
منابع مشابه
Relationship between Anti-Thyroid Peroxidase Antibody and Thyroid Function Test
Background: Anti-thyroid peroxidase antibody (anti-TPO antibody) is a member of thyroid autoantibodies which are important in inducing and also diagnosing autoimmune thyroid diseases. Thyroid autoimmunity can cause several forms of thyroiditis and abnormal thyroid functions, ranging from hypothyroidism to hyperthyroidism. Objective: To evaluate the relationship between serum levels of anti-TPO ...
متن کاملArrayed protein library technology for therapeutic biologic discovery.
The first monoclonal antibody was appproved for human clinical use in 1985. This antibody, OKT3 (Kung et al., 1979), was derived from a mouse hybridoma and produced anti-mouse reactions that limited its use, and hindered further development of monoclonal antibodies. Humanization technology eliminated these cross-species issues and resulted in the approval of the first recombinant “chimeric” ant...
متن کاملAn immune programming-based ranking function discovery approach for effective information retrieval
In this paper, we propose RankIP, the first immune programming (IP) based ranking function discovery approach. IP is a novel evolution based machine learning algorithm with the principles of immune systems, which is verified to be superior to Genetic Programming (GP) on the convergence of algorithm according to their experimental results in Musilek et al. (2006). However, such superiority of IP...
متن کاملPhage display-derived human antibodies in clinical development and therapy
Over the last 3 decades, monoclonal antibodies have become the most important class of therapeutic biologicals on the market. Development of therapeutic antibodies was accelerated by recombinant DNA technologies, which allowed the humanization of murine monoclonal antibodies to make them more similar to those of the human body and suitable for a broad range of chronic diseases like cancer and a...
متن کاملAssessment of protection against SARS-CoV-2 infection by measuring antibody titer, yes or no!
Dear Editor The current epidemic of the novel Coronavirus disease 2019 (COVID-19) risen from Wuhan, China, turned into a worldwide concern because of its incubation period (2-14 days) and its high transmission rate. The first cases of the infection were reported in December 2019 in Wuhan with symptoms like pneumonia for an unknown reason. Very soon it was known as a novel kind of Coronavirus o...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره 2 شماره
صفحات -
تاریخ انتشار 2013